Abstract
Poor responders present one of the major challenges in assisted reproductive technology. Despite numerous protocols devised to achieve optimal stimulation, these patients face high risk of cycle cancellation and implantation failure. Our aim was to assess the efficacy of a novel protocol introducing estradiol (E2) patches and GnRH-antagonist in the luteal phase of the preceding menstrual cycle followed by high dose follicular phase gonadotropin stimulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
